Saturday, December 10, 2022
wellness India Expo
Home Tags Rahul Koul

Tag: Rahul Koul

BioVoice eMagazine December 2022 Issue 3 Volume 3

Click to Read: BioVoice News December 2022 Issue 3 Volume 3 The Cover Story in the current edition focuses on India's strong biotech R&D segment...

FACE TO FACE: Amol Naikawadi, Joint Managing Director, Indus Health Plus

In a highly informative conversation with Rahul Koul, Chief Editor, BioVoice News, the Joint Managing Director of Indus Health Plus, Amol Naikawadi shared his...

BioVoice eMagazine November 2022 Issue 2 Volume 3

Click to Read: BioVoice News November 2022 Issue 2 Volume 3 The Cover Story in the current edition turns its spotlight on the genetically modified mustard. Its recent...

FACE TO FACE: Mahesh Pratapneni, Co-founder & Group CEO, MedGenome

In a highly informative conversation with Rahul Koul, Chief Editor, BioVoice News, the Co-founder & Group CEO of MedGenome, Mahesh Pratapneni, demystifies the concept of...

“We want to be at the forefront of genetic diagnostic revolution”

Subhamoy Dastidar, Co-Founder and Director, Lilac Insights believes that there has been a growing acceptance of genetic testing in India

FACE to FACE: Abhishek Mohan, Founder & CEO, HempStreet

Click to watch the full interview Abhishek Mohan, Founder and Chief Executive Officer, HempStreet has been in the startup space for over 15 years now....

“India continues to remain a key destination for clinical trials”

Jinu Jose, Vice President, Head – Sales and Clinical Operations, R&D Solutions, IQVIA India shared his views on the company's current operations, market scenario and future outlook

Digitalization has democratized healthcare: Experts at BioVoice News e-Conference

Prominent digital healthcare stakeholders shared their valuable insights at the e- Conference on "India’s roadmap to Digital Healthcare: Challenges & Opportunities" organized by the BioVoice News on April 30, 2022

BioVoice News to organize e-Conference on ‘Digital Laboratories: The Emerging Era...

This e-Conference on March 30, 2022 from 3:00 PM - 4:30 PM IST aims to highlight fresh insights on the digitally powered smart labs for the awareness of the stakeholders in biopharmaceutical R&D ecosystem

BioAsia 2022: India’s biotech sector stakeholders discuss learnings from pandemic

Normally a vaccine development process takes 6-8 years for research and trials, but path-breaking work has been done in India